Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Inventory (2022 - 2025)

Lucid Diagnostics' Inventory history spans 4 years, with the latest figure at $353000.0 for Q4 2025.

  • For Q4 2025, Inventory rose 3.52% year-over-year to $353000.0; the TTM value through Dec 2025 reached $353000.0, up 3.52%, while the annual FY2025 figure was $353000.0, 3.52% up from the prior year.
  • Inventory reached $353000.0 in Q4 2025 per LUCD's latest filing, down from $486000.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $683000.0 in Q2 2024 to a low of $111000.0 in Q4 2022.
  • Average Inventory over 4 years is $430200.0, with a median of $447000.0 recorded in 2024.
  • Peak YoY movement for Inventory: soared 150.45% in 2023, then decreased 26.06% in 2025.
  • A 4-year view of Inventory shows it stood at $111000.0 in 2022, then surged by 150.45% to $278000.0 in 2023, then grew by 22.66% to $341000.0 in 2024, then grew by 3.52% to $353000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Inventory are $353000.0 (Q4 2025), $486000.0 (Q3 2025), and $505000.0 (Q2 2025).